X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (79) 79
humans (75) 75
female (58) 58
male (58) 58
aged (49) 49
oncology (48) 48
cancer (40) 40
middle aged (38) 38
united states - epidemiology (38) 38
seer program (37) 37
aged, 80 and over (36) 36
mortality (30) 30
article (28) 28
prevalence (28) 28
public, environmental & occupational health (27) 27
adult (26) 26
incidence (26) 26
abridged index medicus (23) 23
prostate cancer (22) 22
survival (22) 22
united states (21) 21
care and treatment (19) 19
neoplasms - epidemiology (19) 19
prostatic neoplasms - mortality (19) 19
survival analysis (19) 19
survival rate (19) 19
united-states (19) 19
research (18) 18
risk factors (18) 18
age factors (17) 17
breast neoplasms - mortality (17) 17
diagnosis (17) 17
epidemiology (17) 17
medicare (16) 16
neoplasms - mortality (16) 16
registries (16) 16
models, statistical (15) 15
prostate-specific antigen (14) 14
breast-cancer (13) 13
analysis (12) 12
colorectal neoplasms - mortality (12) 12
comorbidity (11) 11
patient outcomes (11) 11
prostatic neoplasms - diagnosis (11) 11
surveillance (11) 11
trends (11) 11
adolescent (10) 10
breast neoplasms - epidemiology (10) 10
forecasting (10) 10
health aspects (10) 10
health care sciences & services (10) 10
mass screening (10) 10
neoplasm staging (10) 10
prostatic neoplasms (10) 10
risk (10) 10
colorectal neoplasms - epidemiology (9) 9
colorectal-cancer (9) 9
computer simulation (9) 9
life expectancy (9) 9
life tables (9) 9
lung (9) 9
population (9) 9
prostate-specific antigen - blood (9) 9
seer program - statistics & numerical data (9) 9
time factors (9) 9
usage (9) 9
young adult (9) 9
breast cancer (8) 8
cancer patients (8) 8
colorectal cancer (8) 8
lung neoplasms - mortality (8) 8
models (8) 8
prognosis (8) 8
prostate (8) 8
prostatic neoplasms - epidemiology (8) 8
public health (8) 8
seer (8) 8
age distribution (7) 7
breast neoplasms - diagnosis (7) 7
chemotherapy (7) 7
child (7) 7
child, preschool (7) 7
colorectal neoplasms - economics (7) 7
infant (7) 7
medical screening (7) 7
medicine, general & internal (7) 7
prostate-cancer (7) 7
quality-of-life (7) 7
regression analysis (7) 7
statistics (7) 7
therapy (7) 7
trial (7) 7
age (6) 6
breast (6) 6
cancer survivors (6) 6
cause of death (6) 6
cohort (6) 6
cohort studies (6) 6
early detection of cancer (6) 6
infant, newborn (6) 6
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, ISSN 1055-9965, 06/2019, Volume 28, Issue 9, pp. cebp.0125.2019 - 1551
We investigated differences in net cancer survival (survival observed if the only possible cause of death was the cancer under study) estimated using new... 
Index Medicus
Journal Article
Journal of the National Cancer Institute. Monographs, 05/2015, Volume 2015, Issue 51, pp. 97 - 97
Journal Article
CA: A Cancer Journal for Clinicians, ISSN 0007-9235, 07/2016, Volume 66, Issue 4, pp. 271 - 289
The number of cancer survivors continues to increase because of both advances in early detection and treatment and the aging and growth of the population. For... 
prevalence | survivorship | treatment patterns | statistics | LYMPH-NODE DISSECTION | ADJUVANT CHEMOTHERAPY | SELECTIVE BLADDER PRESERVATION | LONG-TERM SURVIVORS | BREAST-CONSERVING THERAPY | METASTATIC PROSTATE-CANCER | ANDROGEN-DEPRIVATION THERAPY | ONCOLOGY | COLORECTAL-CANCER | CARDIOVASCULAR-DISEASE | QUALITY-OF-LIFE | Uterine Neoplasms - therapy | United States - epidemiology | Prevalence | Humans | Middle Aged | Survivors - statistics & numerical data | Child, Preschool | National Cancer Institute (U.S.) | Infant | Male | Neoplasms - diagnosis | Incidence | Prostatic Neoplasms - therapy | Breast Neoplasms - therapy | American Cancer Society | Neoplasms - therapy | Skin Neoplasms - mortality | Aged, 80 and over | Uterine Neoplasms - mortality | Adult | Female | Registries | Child | Infant, Newborn | Colonic Neoplasms - therapy | Colonic Neoplasms - mortality | Skin Neoplasms - therapy | Risk Factors | Neoplasms - mortality | Survival Rate | Evidence-Based Medicine | Prostatic Neoplasms - mortality | Adolescent | Breast Neoplasms - mortality | Aged | Melanoma - therapy | Neoplasms - epidemiology | Melanoma - mortality | Care and treatment | Management | Primary health care | Analysis | Public health | Cancer | Survivor | Oncology | Family medical history | Disease management | Medical diagnosis | Medical statistics | Primary care | Index Medicus | Abridged Index Medicus
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 07/2016, Volume 25, Issue 7, pp. 1029 - 1036
Journal Article
Annals of Internal Medicine, ISSN 0003-4819, 06/2009, Volume 150, Issue 12, pp. 849 - 857
Journal Article
Cancer Epidemiology Biomarkers and Prevention, ISSN 1055-9965, 06/2017, Volume 26, Issue 6, pp. 809 - 815
Journal Article
Cancer, ISSN 0008-543X, 09/2017, Volume 123, Issue 17, pp. 3326 - 3334
Some patients with diffuse large B‐cell lymphoma may be cured of their cancer but continue to experience excess mortality from lymphoma and other noncancer... 
causes of death | standardized mortality ratio | rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R‐CHOP) | noncancer causes of death | cure | diffuse large B‐cell lymphoma | Surveillance, Epidemiology, and End Results (SEER) | cancer‐specific survival | cancer-specific survival | diffuse large B-cell lymphoma | rituximab with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) | UNITED-STATES | vincristine | EVENT-FREE SURVIVAL | PHASE-II | RISK | and End Results (SEER) | CHOP CHEMOTHERAPY | Epidemiology | CHEMOTHERAPY PLUS RITUXIMAB | rituximab with cyclophosphamide | TRIAL | THERAPY | Surveillance | ONCOLOGY | NON-HODGKIN-LYMPHOMA | doxorubicin | and prednisone (R-CHOP) | ELDERLY-PATIENTS | Predictive Value of Tests | Immunotherapy - methods | Age Factors | United States | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Cause of Death | Neoplasm Invasiveness - pathology | Aged, 80 and over | Adult | Female | Retrospective Studies | Databases, Factual | SEER Program | Lymphoma, Large B-Cell, Diffuse - drug therapy | Lymphoma, Large B-Cell, Diffuse - pathology | Risk Assessment | Proportional Hazards Models | Combined Modality Therapy | Lymphoma, Large B-Cell, Diffuse - mortality | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Sex Factors | Survival Analysis | Aged | Neoplasm Staging | Cancer patients | Chemotherapy | Usage | Lymphocytic leukemia | Diagnosis | Health aspects | Cancer | Cell survival | Gastrointestinal tract diseases | Risk groups | Mortality | Medical services | Patients | Survival | Lymphoma | Risk factors | Diseases | Extrapolation | Demographics | Vascular diseases | Lymphocytes B | Mathematical analysis | Risk assessment | Fatalities | Lymphomas | Health risk assessment | B-cell lymphoma | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the National Cancer Institute Monographs, ISSN 1052-6773, 11/2014, Volume 2014, Issue 49, pp. 255 - 264
Background To isolate progress against cancer from changes in competing causes of death, population cancer registries have traditionally reported cancer... 
Colonic Neoplasms - mortality | SEER Program | Prognosis | Age Factors | Risk Assessment | Comorbidity | Lung Neoplasms - mortality | United States | Humans | Middle Aged | Male | Survival Rate | Cause of Death | Prostatic Neoplasms - mortality | Young Adult | Aged, 80 and over | Adult | Breast Neoplasms - mortality | Female | Aged | Neoplasm Staging | Index Medicus
Journal Article
Cancer, ISSN 0008-543X, 05/2014, Volume 120, Issue 9, pp. 1290 - 1314
Journal Article
Journal of the National Cancer Institute. Monographs, ISSN 1052-6773, 2006, Issue 36, pp. 19 - 25
Journal Article